Summary. The activities of twelve steroids and fifteen non-steroids are reported for tests in mice of oestrogenic and anti-oestrogenic activity (vaginal smear) and antifertility activity (administration in early pregnancy). No steroid, with the possible exception of 17\g=a\-(2'-methallyl)-9\g=b\,10\g=a\-androst-4-en-17-ol-3-one(SAP 104), had antifertility effects not explained by its oestrogenic activity. Among the non-steroids, meso\g=a\,\g=a\'-dimethyl-4,4'-dihydroxybibenzyl (meso-dma), 1 -[p-(2-diethylaminoethoxy) phenyl]-2-(p-methoxyphenyl)-1-phenylethane (MRL 37) and possibly 1-[p-(2-diethylaminoethoxy)phenyl]-2-(p-methoxyphenyl)-1-phenylethanol (MER 25) may have antifertility effects unrelated or incompletely related to oestrogenic activity and possibly related to antioestrogenic activity.
INTRODUCTION
The phenomenon of anti-oestrogenic activity and the elaboration of com¬ pounds exhibiting it have occupied increasing attention over the past few years. A short time ago, only the natural antagonists to oestrogens, progesterone and some of the androgens, were known in some circumstances to show antioestrogenic properties. Now, a number of synthetic steroids and several series of non-steroidal compounds have been shown to antagonize various activities of oestrogens, and there is reason to believe that some, at least, of these compete with oestrogens at their site of action (Emmens, Cox & Martin, 1962) .
There seems to be a high correlation between oestrogenic and anti-oestrogenic activity (Emmens, Cox & Martin, 1964) in series like the stilboestrols, which is not surprising if weakly active oestrogens or pro-oestrogens (Emmens, 1941) compete with the potent compounds for the same transport or receptor sites. This correlation has made it difficult to decide whether the antifertility activity shown by many of these substances in rodents may be due to the well-known action of oestrogens or to anti-oestrogenic properties, and various attempts to decide the question have not been conclusive (cf. Martin, Cox & Emmens, 1963; Emmens et al., 1964) . However, Emmens (1965) has, by further detailed analysis of the activities of dimethylstilboestrol (dms) by different routes in the rat and mouse, decided that in the case of that particular substance the antifertility effect is very probably due to its pro-oestrogenic action. The action of dms in suppressing deciduoma reactions in the rat and mouse also parallels that of oestradiol (Stone & Emmens, 1964a, b) The contrast in type of anti-oestrogenic activity between steroids and other compounds has been discussed earlier (Emmens et al., 1962) Scholer (1963) to be active in this respect if given prior to mating in the rodent. This has been confirmed, but appears to be due to failure to mate in the mouse and is the subject of further testing yet to be completed. (ii) U-l 1100A, which has peculiar properties and is the subject of a separate paper (Emmens & Martin, 1965) . Although its oestrogenic activity would seem to explain its antifertility properties, it is an incomplete oestrogen with seemingly self-inhibitory properties.
(iii) MRL 37, which is not oestrogenic in doses up to 8 mg in the mouse, nevertheless inhibits early pregnancy in daily doses of 0-8 to 1-6 mg. It shows some anti-oestrogenic action subcutaneously at 1 mg in the mouse.
(iv) MER 25, the subject of much previous discussion, is alleged to be cytotoxic and to owe its antifertility actions to this activity (Segal & Nelson, 1958) . How¬ ever, it shows oestrogenic activity in high doses, and may owe its antifertility action to this. Humphrey & Martin (1965) have shown that the degeneration of ova under the influence of MER 25 is paralleled by that seen with oestradiol, and the effects of both may be connected with delay in passage through the fallopian tubes.
Anti-oestrogenic and oestrogenic activity are both seen in many of the com¬ pounds listed in Table 2 . These, in some cases at least, are compounds which antagonize in the tetrazolium reduction test, and may be presumed to displace oestrogen from its site of action and to prevent even its earliest activities. An exception is MER 25, which although active locally in high enough doses, does not reduce the response to oestradiol in the tetrazolium reduction test.
These results would, therefore, seem to lead to the conclusion that in the general run of compounds tested, particularly the steroids, antifertility activity is due to oestrogenic properties. There are, however, some exceptions which merit further work and the investigation of allied compounds, in that oestro¬ genic action does not appear to explain the antifertility potency found. In one or two cases, anti-oestrogenic activity still remains a possible explanation of antifertility effects.
